Back to search

National and Kapodistrian University of Athens

Διερεύνηση μοριακών μηχανισμών και υποψήφιων θεραπευτικών ουσιών για την επιληψία πρώιμης έναρξης με μεθόδους βιοπληροφορικής

Abstract

dc:description

Epilepsy is a severe common neurological disease affecting all ages, with age of onset that differs. Epilepsy with onset before the age of 5 years, designated early-onset epilepsy (EOE), is of special importance. According to previous studies, genetic factors contribute significantly to the pathogenesis of epilepsy and EOE that remain unclear and must be explored. So, after creating a database with genes associated with epilepsy (and relevant information about them), a list of 229 well-selected EOE-associated genes expressed in the brain was created for the investigation of genetic factors and molecular mechanisms involved in its pathogenesis. Enrichment analysis showed that among significant pathways were nicotine addiction, GABAergic synapse, synaptic vesicle cycle, regulation of membrane potential, cholinergic synapse, dopaminergic synapse, and morphine addiction. Performing an integrated analysis as well as protein-protein interaction network-based approaches with the use of GO, KEGG, ClueGO, cytoHubba and 3 network metrics, 12 hub genes were identified, eight of which, CDKL5, GABRA1, KCNQ2, KCNQ3, SCN1A, SCN2A, SCN8A and STXBP1, were identified as key genes (via Venn diagram analysis). These key genes are mostly enriched in SNARE interactions in vesicular transport, regulation of membrane potential and synaptic vesicle exocytosis. Clustering analysis of the PPI network via MCODE showed significant functional modules, indicating also other pathways such as protein N-linked glycosylation, retrograde endocannabinoid signaling, mTOR signaling and aminoacyl-tRNA biosynthesis. Drug-gene interaction analysis identified a number of drugs as potential medications for EOE, among which the FDA approved drug retigabine and the non-FDA approved drug azetukalner (that is under clinical development).

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Boulaki, Vasiliki-Stamatia
  • Μπουλάκη, Βασιλική-Σταματία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59925

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Boulaki, Vasiliki-Stamatia; Μπουλάκη, Βασιλική-Σταματία. Διερεύνηση μοριακών μηχανισμών και υποψήφιων θεραπευτικών ουσιών για την επιληψία πρώιμης έναρξης με μεθόδους βιοπληροφορικής. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/59925